AAAAAA

   
Results: 1-8 |
Results: 8
ANTIVIRAL AND RESISTANCE STUDIES OF AG1343, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE (VOL 40, PG 294, 1996)
Authors: PATICK AK MO H MARKOWITZ M APPELT K WU B MUSICK L KALISH V KALDOR S REICH S HO D WEBBER S
Citation: Ak. Patick et al., ANTIVIRAL AND RESISTANCE STUDIES OF AG1343, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE (VOL 40, PG 294, 1996), Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1575-1575
ANTIVIRAL AND RESISTANCE STUDIES OF AG1343, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE
Authors: PATICK AK MARKOWITZ M APPELT K WU B MUSICK L KALISH V KALDOR S REICH S HO D WEBBER S
Citation: Ak. Patick et al., ANTIVIRAL AND RESISTANCE STUDIES OF AG1343, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 292-297
STRUCTURE-BASED DESIGN AND SYNTHESIS OF SUBSTITUTED 2-BUTANOLS AS NONPEPTIDIC INHIBITORS OF HIV PROTEASE - SECONDARY AMIDE SERIES
Authors: REICH SH MELNICK M PINO MJ FUHRY MAM TRIPPE AJ APPELT K DAVIES JF WU BW MUSICK L
Citation: Sh. Reich et al., STRUCTURE-BASED DESIGN AND SYNTHESIS OF SUBSTITUTED 2-BUTANOLS AS NONPEPTIDIC INHIBITORS OF HIV PROTEASE - SECONDARY AMIDE SERIES, Journal of medicinal chemistry, 39(14), 1996, pp. 2781-2794
BIS TERTIARY AMIDE INHIBITORS OF THE HIV-1 PROTEASE GENERATED VIA PROTEIN STRUCTURE-BASED ITERATIVE DESIGN
Authors: MELNICK M REICH SH LEWIS KK MITCHELL LJ NGUYEN D TRIPPE AJ DAWSON H DAVIES JF APPELT K WU BW MUSICK L GEHLHAAR DK WEBBER S SHETTY B KOSA M KAHIL D ANDRADA D
Citation: M. Melnick et al., BIS TERTIARY AMIDE INHIBITORS OF THE HIV-1 PROTEASE GENERATED VIA PROTEIN STRUCTURE-BASED ITERATIVE DESIGN, Journal of medicinal chemistry, 39(14), 1996, pp. 2795-2811
STRUCTURE-BASED DRUG DESIGN OF NONPEPTIDIC P-2 SUBSTITUENTS FOR HIV-1PROTEASE INHIBITORS
Authors: KALISH VJ TATLOCK JH DAVIES JF KALDOR SW DRESSMAN BA REICH S PINO M NYUGEN D APPELT K MUSICK L WU BW
Citation: Vj. Kalish et al., STRUCTURE-BASED DRUG DESIGN OF NONPEPTIDIC P-2 SUBSTITUENTS FOR HIV-1PROTEASE INHIBITORS, Bioorganic & medicinal chemistry letters, 5(7), 1995, pp. 727-732
ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
Authors: KALISH V KALDOR S SHETTY B TATLOCK J DAVIES J HAMMOND M DRESSMAN B FRITZ J APPELT K REICH S MUSICK L WU BW SU K
Citation: V. Kalish et al., ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS, European journal of medicinal chemistry, 30, 1995, pp. 201-214
PROTEIN STRUCTURE-BASED DESIGN OF POTENT ORALLY BIOAVAILABLE, NONPEPTIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE
Authors: REICH SH MELNICK M DAVIES JF APPELT K LEWIS KK FUHRY MA PINO M TRIPPE AJ NGUYEN D DAWSON H WU BW MUSICK L KOSA M KAHIL D WEBBER S GEHLHAAR DK ANDRADA D SHETTY B
Citation: Sh. Reich et al., PROTEIN STRUCTURE-BASED DESIGN OF POTENT ORALLY BIOAVAILABLE, NONPEPTIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3298-3302
CRYSTAL-STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL C-TERMINAL INHIBITORS OF HIV PROTEASE
Authors: VARNEY MD APPELT K KALISH V REDDY MR TATLOCK J PALMER CL ROMINES WH WU BW MUSICK L
Citation: Md. Varney et al., CRYSTAL-STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL C-TERMINAL INHIBITORS OF HIV PROTEASE, Journal of medicinal chemistry, 37(15), 1994, pp. 2274-2284
Risultati: 1-8 |